Jean-Simon Diallo

Researcher

Ottawa Hospital Research Institute

Related Research

Related News & Events

Research Highlight|December 14, 2023

Study finds new clinical trial drug boosts ability of oncolytic virus to target and kill cancer

Researchers at The Ottawa Hospital have identified a method to boost the activity of cancer-fighting viruses by pairing one with a new cancer drug cur...

Research Highlight|May 14, 2019

TFRI-funded scientists publish snapshot on oncolytic viruses in top scientific journal

Members of a long-standing TFRI team focused on developing cancer-killing viruses have published a snapshot article summarizing this promising area of...

Research Highlight|February 15, 2018

Vanadium compounds enhance efficacy of oncolytic viruses when used in combination therapy

A new class of compounds is generating excitement for its ability to enhance the efficacy of oncolytic viruses (OVs) and to stimulate the immune respo...

Research Highlight|September 29, 2016

New class of small molecules enhances OV replication

An innovative paper by Dr. Jean-Simon Diallo (TFRI-funded Canadian Oncolytic Virus Consortium (COVCo) and collaborators Drs. Jeffrey Smith and Christ...

Research Highlight|April 23, 2015

Viruses and drugs combine to form potent anti-cancer therapy

Ottawa, ON -- Terry Fox-funded researcher, Dr. Jean-Simon Diallo and his colleagues at the Ottawa Hospital Research Institute have discovered that com...

All News & Events

Jean-Simon Diallo

Funding Opportunities

Our Research

Impact

About Cancer

Updates

About Us

Contact